论文部分内容阅读
目前开展计划免疫使用的疫苗简介一、卡介苗 (一)概述卡介苗是活菌苗,由无毒牛型结核杆菌制成,主要用于预防结核病。卡介苗于1921年始用于法国。到1979年底为止,接种已超过14.7亿人次。目前WHO(世界卫生组织)将卡介苗列入扩大免疫计划,并提出近期目标为到1990年时,全世界需要预防接种的儿童都能种上卡介苗等6个制品。卡介苗的应用,在我国开始于1933年由王良在重庆使用,大力推广乃在解放以后。到1979年底为止,全国已接种了近五亿人次。
Brief introduction of vaccines currently planned to be used for immunization 1. Bacille Calmette-Guerin (A) Overview Bacille Calmette-Guerin is a live vaccine made of non-toxic bovine Mycobacterium tuberculosis and is mainly used for the prevention of tuberculosis. BCG was used in France in 1921. By the end of 1979, more than 1.47 billion people had been vaccinated. Currently, the WHO (World Health Organization) includes BCG in the expanded immunization program and proposes that the immediate goal is that by the year 1990, all children in need of vaccination worldwide should be able to grow 6 products, including BCG. The application of BCG in our country began in 1933 by Wang Liang in Chongqing to use, to promote but after the liberation. By the end of 1979, nearly 500 million people had been vaccinated throughout the country.